7,8-diacetoxy-3-(3,4-diacetoxyphenyl)coumarin

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 异黄酮类化合物
• 英文名称: 7,8-diacetoxy-3-(3,4-diacetoxyphenyl)coumarin
• 英文别名: [2-Acetyloxy-4-(7,8-diacetyloxy-2-oxochromen-3-yl)phenyl] acetate；[2-acetyloxy-4-(7,8-diacetyloxy-2-oxochromen-3-yl)phenyl] acetate
• 化学式: C₂₃H₁₈O₁₀
• 分子量: 454.39
• InChiKey: OHAAEKGFYBJKGU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  33
• 可旋转键数：
  9
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  132
• 氢给体数：
  0
• 氢受体数：
  10

反应信息

• 作为反应物：
  描述：

  7,8-diacetoxy-3-(3,4-diacetoxyphenyl)coumarin 在 盐酸 作用下， 以 甲醇 、 水 为溶剂， 反应 3.0h， 生成 7,8-dihydroxy-3-(3',4'-dihydroxyphenyl)coumarin
  参考文献：
  名称：

  一系列选定的羟基-3-芳基香豆素的合成，抗氧化剂和抗chachagas性质

  摘要：

  氧化应激与查加斯（Chagas）等几种寄生虫病有关。能够选择性调节与疾病有关的生化过程的药物代表了有希望的多功能药物，可延缓或消除这种病理学进程。在当前的工作中，描述了不同取代的羟基-3-芳基香豆素，既发挥抗氧化剂活性又具有锥虫活性。在合成的化合物中，化合物8表现出最令人关注的特性，表现出对过氧自由基的适度清除能力（ORAC-FL = 2.23），并且对寄生克鲁维氏酵母的副鞭毛阶段具有高度选择性（IC 50 = 1.31μM），高于Nifurtimox（目前用于治疗南美锥虫病的药物）。有趣的是，当前的研究表明，羟基-3-芳基香豆素核心的细微结构变化允许调节这两种活性，这表明该支架对于开发有前途的抗chachagasic化合物具有理想的特性。

  DOI：

  10.1016/j.bmc.2016.11.033
• 作为产物：
  描述：

  3,4-二乙酰氧基苯乙酸 、 在 potassium acetate 、 乙酸酐 作用下， 反应 16.0h， 以54%的产率得到7,8-diacetoxy-3-(3,4-diacetoxyphenyl)coumarin
  参考文献：
  名称：

  Structure-Based Optimization of Coumarin hA₃ Adenosine Receptor Antagonists

  摘要：

  Adenosine receptors participate in many physiological functions. Molecules that may selectively interact with one of the receptors are favorable multifunctional chemical entities to treat or decelerate the evolution of different diseases. 3-Arylcoumarins have already been studied as neuroprotective agents by our group. Here, differently 8-substituted 3-arylcoumarins are complementarily studied as ligands of adenosine receptors, performing radioligand binding assays. Among the synthesized compounds, selective A(3) receptor antagonists were found. 3-(4-Bromophenyl)-8-hydroxycoumarin (compound 4) displayed the highest potency and selectivity as A(3) receptor antagonist (K-i = 258 nM). An analysis of its X-ray diffraction provided detailed information on its structure. Further evaluation of a selected series of compounds indicated that it is the nature and position of the substituents that determine their activity and selectivity. Theoretical modeling calculations corroborate and explain the experimental data, suggesting this novel scaffold can be involved in the generation of candidates as multitarget drugs.

  DOI：

  10.1021/acs.jmedchem.9b01572

文献信息

• Synthesis, antioxidant and antichagasic properties of a selected series of hydroxy-3-arylcoumarins
  作者：Natalia Robledo-O’Ryan、Maria João Matos、Saleta Vazquez-Rodriguez、Lourdes Santana、Eugenio Uriarte、Mauricio Moncada-Basualto、Francisco Mura、Michel Lapier、Juan Diego Maya、Claudio Olea-Azar

  DOI：10.1016/j.bmc.2016.11.033

  日期：2017.1

  disease). Interestingly, the current study revealed that small structural changes in the hydroxy-3-arylcoumarin core allow modulating both activities, suggesting that this scaffold has desirable properties for the development of promising classes of antichagasic compounds.

  氧化应激与查加斯（Chagas）等几种寄生虫病有关。能够选择性调节与疾病有关的生化过程的药物代表了有希望的多功能药物，可延缓或消除这种病理学进程。在当前的工作中，描述了不同取代的羟基-3-芳基香豆素，既发挥抗氧化剂活性又具有锥虫活性。在合成的化合物中，化合物8表现出最令人关注的特性，表现出对过氧自由基的适度清除能力（ORAC-FL = 2.23），并且对寄生克鲁维氏酵母的副鞭毛阶段具有高度选择性（IC 50 = 1.31μM），高于Nifurtimox（目前用于治疗南美锥虫病的药物）。有趣的是，当前的研究表明，羟基-3-芳基香豆素核心的细微结构变化允许调节这两种活性，这表明该支架对于开发有前途的抗chachagasic化合物具有理想的特性。
• Structure-Based Optimization of Coumarin hA₃ Adenosine Receptor Antagonists
  作者：Maria João Matos、Santiago Vilar、Saleta Vazquez-Rodriguez、Sonja Kachler、Karl-Norbert Klotz、Michela Buccioni、Giovanna Delogu、Lourdes Santana、Eugenio Uriarte、Fernanda Borges

  DOI：10.1021/acs.jmedchem.9b01572

  日期：2020.3.12

  Adenosine receptors participate in many physiological functions. Molecules that may selectively interact with one of the receptors are favorable multifunctional chemical entities to treat or decelerate the evolution of different diseases. 3-Arylcoumarins have already been studied as neuroprotective agents by our group. Here, differently 8-substituted 3-arylcoumarins are complementarily studied as ligands of adenosine receptors, performing radioligand binding assays. Among the synthesized compounds, selective A(3) receptor antagonists were found. 3-(4-Bromophenyl)-8-hydroxycoumarin (compound 4) displayed the highest potency and selectivity as A(3) receptor antagonist (K-i = 258 nM). An analysis of its X-ray diffraction provided detailed information on its structure. Further evaluation of a selected series of compounds indicated that it is the nature and position of the substituents that determine their activity and selectivity. Theoretical modeling calculations corroborate and explain the experimental data, suggesting this novel scaffold can be involved in the generation of candidates as multitarget drugs.